<DOC>
	<DOCNO>NCT00046462</DOCNO>
	<brief_summary>The purpose study determine whether blood sugar control different Lantus third oral anti-diabetic agent add patient fail thiazolidinedione sulfonylurea metformin combination .</brief_summary>
	<brief_title>Determine Whether Glycemic Control Different Between Lantus &amp; 3rd Oral Agent When Failure With Other Treatment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>2,4-thiazolidinedione</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Patients 18 79 year age With diagnosed type 2 diabetes least year treat stable dos two oral antidiabetic drug one either Avandia Actos least three month Major cardiovascular event The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>